Skip to content

Clinical trials

Phase 2 Astrocytoma trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Astrocytoma Phase: Phase 2 Country / region: Canada Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20022
20031
20051
20061
20081
20101
20122
20171
20181
20211
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Recruiting3
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)7
Children's Oncology Group4
Day One Biopharmaceuticals, Inc.1
Duke University1
Exelixis1
NCIC Clinical Trials Group1
Nationwide Children's Hospital1
Novartis Pharmaceuticals1
Ottawa Regional Cancer Centre1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Astrocytoma23
Central Nervous System Neoplasms13
Oligodendroglioma11
Brain Neoplasms10
Glioma9
Glioblastoma8
Optic Nerve Glioma8
Medulloblastoma5
Sarcoma4
Gliosarcoma3

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.